An engineered virus kills cancer cells more effectively than another virus currently used in treatments, according to Hokkaido University researchers.
Hokkaido University researchers have engineered a virus that selectively targets and kills cancer cells. The virus, called dl355, has an even stronger anticancer effect than another engineered virus currently used in clinical practice, according to a study published in the journal Oncology Reports.
Molecular oncologist Fumihiro Higashino and colleagues deleted a gene involved in viral replication, called E4orf6, from a type of adenovirus. The team previously discovered that E4orf6 stabilizes a type of mRNA called ARE-mRNAs in the infected cells enabling viral replication. ARE-mRNAs are known to be stable in stressed cells and cancer cells, but rapidly degrade in normal cells.
In laboratory tests, they found that their modified adenovirus, called dl355, replicated and increased its number significantly more in cancer cells than it did in normal cells. Higashino explains “The E4orf6-lacking virus relies on the stable ARE-mRNAs in cancer cells for its replication.”
Some viruses can be used to treat cancers, as they replicate within the cells until they burst and die. The researchers infected several types of cultured cancer cells with 100 dl355 virus particles per cell and found that nearly all the cancer cells died within seven days. In contrast, most normal cells infected with the virus did not die, even after seven days. Several cancer cell lines managed to survive low doses of dl355, but all cancer cells were killed by the virus as the dose was increased. Tumour growth was also significantly suppressed when dl355 was administered to human tumour cells grown in mice.
Finally, the team compared the anticancer effects of dl355 with another anticancer adenovirus currently used in clinical practice, called dl1520. dl355 replication was higher in all cancer cell lines tested, including cervical and lung cancer cells, and was better at killing all but one type of cancer cell, compared to dl1520. Both viruses only killed very few normal cells.
The findings suggest that dl355 has potential to be an effective anticancer treatment, the team concludes. They suggest enhancing the stabilization of ARE-mRNAs in cancer cells could even further strengthen its effect, but Professor Higashino notes that further research is required. “While we think dl355 has the potential to be an effective treatment method in dealing with many types of cancers, much more research needs to be done. When we think of a timeline, at least five more years of further research may be required, possible more, on top of clinical trials,” Professor Higashino noted.
Learn more: Engineering a cancer-fighting virus
The Latest on: Engineered virus
via Google News
The Latest on: Engineered virus
- The Rules of Golf have been modified to help combat the coronaviruson March 22, 2020 at 1:05 pm
As the world battles the spread of coronavirus, some golf courses (ones that are still open) have found smart and unique ways to allow golfers to keep playing to stay active while also practicing ...
- Golf courses offer respite from virus anxiety, at least for nowon March 21, 2020 at 5:02 pm
Fox Ridge in Auburn opened Saturday with a modified nine-hole course, while employing many of the same precautionary strategies. Dunegrass in Old Orchard Beach is allowing carts, but only one rider ...
- Metro Transit trims schedule as ridership drops amid virus fearson March 21, 2020 at 4:50 pm
Public transportation in the St. Louis region will run on a modified schedule starting Monday to minimize the spread of the new coronavirus. Metro Transit announced the changes Friday, which include ...
- NJ Transit adds some trains back into modified coronavirus rail scheduleon March 21, 2020 at 12:01 pm
NJ Transit said trains will operate on a modified Presidents’ Day schedule staring Monday morning ... announce a shut down of all non-essential businesses in the state Saturday to help stop the spread ...
- Pitt Researchers Attach Coronavirus To Genetically Modified Measles Vaccineon March 20, 2020 at 4:25 pm
The Center for Vaccine Research at Pitt now has successfully taken a portion of the virus that leads to COVID-19 and attached it to a genetically modified measles vaccine that has been used for years.
- 1st Coronavirus Death In DC Confirmed; Closure Orders Modifiedon March 20, 2020 at 3:28 pm
D.C. Mayor Muriel Bowser confirmed the District's first death due to the coronavirus. She also modified closures across the city. WASHINGTON, DC — Mayor Muriel Bowser confirmed the District's first ...
- The new coronavirus was not genetically engineered, study showson March 20, 2020 at 3:14 am
If scientists had engineered the new coronavirus purposely as a pathogen, explain the researchers, the starting point would likely have been the backbone of another virus in the coronavirus family.
- Delivery Robots Could Have Saved The Day If The Virus Had Come A Bit Lateron March 19, 2020 at 11:00 am
Delivery robots are coming, but they're not quite here, which is a shame because we really need them right now, and they are probably safe enough on the empty streets of virus lockdown cities.
- N.Y. lawmakers pass modified sick leave to help workers quarantined due to coronaviruson March 18, 2020 at 4:39 pm
With cases of the quickly spreading respiratory illness rapidly rising in the state — and two of their own absent after contracting the virus — lawmakers practiced “social distancing” by voting in ...
- No Evidence COVID-19 Coronavirus Was Genetically Engineered in a Lab – Epidemic Has a Natural Originon March 18, 2020 at 9:35 am
Scripps Research’s analysis of public genome sequence data from SARS-CoV-2 and related viruses found no evidence that the virus was made in a laboratory or otherwise engineered. The novel SARS-CoV-2 ...
via Bing News